BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16880530)

  • 1. Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage.
    Mourali J; Bénard A; Lourenço FC; Monnet C; Greenland C; Moog-Lutz C; Racaud-Sultan C; Gonzalez-Dunia D; Vigny M; Mehlen P; Delsol G; Allouche M
    Mol Cell Biol; 2006 Aug; 26(16):6209-22. PubMed ID: 16880530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic apoptotic pathway in anaplastic large cell lymphoma.
    Oyarzo MP; Drakos E; Atwell C; Amin HM; Medeiros LJ; Rassidakis GZ
    Hum Pathol; 2006 Jul; 37(7):874-82. PubMed ID: 16784988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
    Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
    Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
    Hsu FY; Johnston PB; Burke KA; Zhao Y
    Cancer Res; 2006 Sep; 66(18):9002-8. PubMed ID: 16982741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the oncogenic NPM-ALK chimeric protein in human lymphoid T-cells inhibits drug-induced, but not Fas-induced apoptosis.
    Greenland C; Touriol C; Chevillard G; Morris SW; Bai R; Duyster J; Delsol G; Allouche M
    Oncogene; 2001 Nov; 20(50):7386-97. PubMed ID: 11704868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of signal transducer and activator of transcription 5 in nucleophosmin/ anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells.
    Nieborowska-Skorska M; Slupianek A; Xue L; Zhang Q; Raghunath PN; Hoser G; Wasik MA; Morris SW; Skorski T
    Cancer Res; 2001 Sep; 61(17):6517-23. PubMed ID: 11522649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the subcellular localization of ALK tyrosine kinase domain in neuronal differentiation of PC12 cells.
    Gouzi JY; Moog-Lutz C; Vigny M; Brunet-de Carvalho N
    J Cell Sci; 2005 Dec; 118(Pt 24):5811-23. PubMed ID: 16317043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In contrast to agonist monoclonal antibodies, both C-terminal truncated form and full length form of Pleiotrophin failed to activate vertebrate ALK (anaplastic lymphoma kinase)?
    Mathivet T; Mazot P; Vigny M
    Cell Signal; 2007 Dec; 19(12):2434-43. PubMed ID: 17904822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of NPM-ALK by siRNA causes anaplastic large cell lymphoma cell growth inhibition and augments the anti cancer effects of chemotherapy in vitro.
    Hsu FY; Zhao Y; Anderson WF; Johnston PB
    Cancer Invest; 2007 Jun; 25(4):240-8. PubMed ID: 17612934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
    Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
    Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients.
    Passoni L; Longo L; Collini P; Coluccia AM; Bozzi F; Podda M; Gregorio A; Gambini C; Garaventa A; Pistoia V; Del Grosso F; Tonini GP; Cheng M; Gambacorti-Passerini C; Anichini A; Fossati-Bellani F; Di Nicola M; Luksch R
    Cancer Res; 2009 Sep; 69(18):7338-46. PubMed ID: 19723661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system.
    Iwahara T; Fujimoto J; Wen D; Cupples R; Bucay N; Arakawa T; Mori S; Ratzkin B; Yamamoto T
    Oncogene; 1997 Jan; 14(4):439-49. PubMed ID: 9053841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase.
    Turner SD; Tooze R; Maclennan K; Alexander DR
    Oncogene; 2003 Oct; 22(49):7750-61. PubMed ID: 14586401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serine phosphorylation of NPM-ALK, which is dependent on the auto-activation of the kinase activation loop, contributes to its oncogenic potential.
    Wang P; Wu F; Zhang J; McMullen T; Young LC; Ingham RJ; Li L; Lai R
    Carcinogenesis; 2011 Feb; 32(2):146-53. PubMed ID: 21045017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomas.
    Thornber K; Colomba A; Ceccato L; Delsol G; Payrastre B; Gaits-Iacovoni F
    Oncogene; 2009 Jul; 28(29):2690-6. PubMed ID: 19503098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model of inhibition of the NPM-ALK kinase activity by herbimycin A.
    Turturro F; Arnold MD; Frist AY; Pulford K
    Clin Cancer Res; 2002 Jan; 8(1):240-5. PubMed ID: 11801565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin.
    Bonvini P; Gastaldi T; Falini B; Rosolen A
    Cancer Res; 2002 Mar; 62(5):1559-66. PubMed ID: 11888936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical screening for oncogenic tyrosine kinase activation.
    Pulford K; Delsol G; Roncador G; Biddolph S; Jones M; Mason DY
    J Pathol; 1999 Apr; 187(5):588-93. PubMed ID: 10398126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma.
    Amin HM; McDonnell TJ; Ma Y; Lin Q; Fujio Y; Kunisada K; Leventaki V; Das P; Rassidakis GZ; Cutler C; Medeiros LJ; Lai R
    Oncogene; 2004 Jul; 23(32):5426-34. PubMed ID: 15184887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALK (Anaplastic Lymphoma Kinase) expression in DRG neurons and its involvement in neuron-Schwann cells interaction.
    Degoutin J; Brunet-de Carvalho N; Cifuentes-Diaz C; Vigny M
    Eur J Neurosci; 2009 Jan; 29(2):275-86. PubMed ID: 19200234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.